COSCIENS Biopharma Inc. (TSX:CSCI)
Canada · Delayed Price · Currency is CAD 4.720
-0.060 (-1.26%)
Jul 14, 2025, 9:30 AM EDT
COSCIENS Biopharma Revenue
COSCIENS Biopharma had revenue of $1.50M USD in the quarter ending March 31, 2025, a decrease of -27.08%. This brings the company's revenue in the last twelve months to $9.03M, up 36.51% year-over-year. In the year 2024, COSCIENS Biopharma had annual revenue of $9.59M with 34.22% growth.
Revenue (ttm)
$9.03M
Revenue Growth
+36.51%
P/S Ratio
1.14
Revenue / Employee
$225.75K
Employees
40
Market Cap
14.82M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| Sienna Senior Living | 896.45M |
| dentalcorp Holdings | 1.58B |
| WELL Health Technologies | 990.34M |
| Trulieve Cannabis | 1.71B |
| Extendicare | 1.47B |
| Cronos Group | 179.08M |
| Curaleaf Holdings | 1.89B |